Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathy Keyvani

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
European Urology Open Science|March 2, 2026
<i>NECTIN4</i> Amplification Is a Frequent Event in Central Nervous System Metastases of Urothelial CarcinomaRichard Weiten, Constantin Rieger, Julian Heidenreich, et al.
Journal of Neurology|May 29, 2024
The multiple roles of nerve biopsy in the diagnosis and prognosis of suspected immune neuropathiesRafael Klimas, Anna Kordes, Sophie Huckemann, et al.
Journal of Neuropathology and Experimental Neurology|December 18, 2012
PDGFRA gain in low-grade diffuse gliomasKazuya Motomura, Michel Mittelbronn, Werner Paulus, et al.
Frontiers in Oncology|May 3, 2021
Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant MelanomaTeresa Schmidt, Sied Kebir, Elisabeth Livingstone, et al.
Frontiers in Immunology|March 3, 2020
Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the BrainDayana Herrera-Rios, Sadaf S Mughal, Sarah Teuber-Hanselmann, et al.
Journal of Cancer Research and Clinical Oncology|August 11, 2022
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent gliomaLazaros Lazaridis, Teresa Schmidt, Christoph Oster, et al.
Cancers|June 10, 2023
Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on PrognosisNika Guberina, Florian Padeberg, Christoph Pöttgen, et al.
The American Journal of Pathology|November 16, 2010
Molecular classification of low-grade diffuse gliomasYoung-Ho Kim, Sumihito Nobusawa, Michel Mittelbronn, et al.
Journal of Cancer Research and Clinical Oncology|December 13, 2019
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastomaLazaros Lazaridis, Niklas Schäfer, Sarah Teuber-Hanselmann, et al.
Clinical Nuclear Medicine|December 6, 2018
Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016Sied Kebir, Manuel Weber, Lazaros Lazaridis, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
European Urology Open Science|March 2, 2026
<i>NECTIN4</i> Amplification Is a Frequent Event in Central Nervous System Metastases of Urothelial CarcinomaRichard Weiten, Constantin Rieger, Julian Heidenreich, et al.
Journal of Neurology|May 29, 2024
The multiple roles of nerve biopsy in the diagnosis and prognosis of suspected immune neuropathiesRafael Klimas, Anna Kordes, Sophie Huckemann, et al.
Journal of Neuropathology and Experimental Neurology|December 18, 2012
PDGFRA gain in low-grade diffuse gliomasKazuya Motomura, Michel Mittelbronn, Werner Paulus, et al.
Frontiers in Oncology|May 3, 2021
Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant MelanomaTeresa Schmidt, Sied Kebir, Elisabeth Livingstone, et al.
Frontiers in Immunology|March 3, 2020
Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the BrainDayana Herrera-Rios, Sadaf S Mughal, Sarah Teuber-Hanselmann, et al.
Journal of Cancer Research and Clinical Oncology|August 11, 2022
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent gliomaLazaros Lazaridis, Teresa Schmidt, Christoph Oster, et al.
Cancers|June 10, 2023
Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on PrognosisNika Guberina, Florian Padeberg, Christoph Pöttgen, et al.
The American Journal of Pathology|November 16, 2010
Molecular classification of low-grade diffuse gliomasYoung-Ho Kim, Sumihito Nobusawa, Michel Mittelbronn, et al.
Journal of Cancer Research and Clinical Oncology|December 13, 2019
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastomaLazaros Lazaridis, Niklas Schäfer, Sarah Teuber-Hanselmann, et al.
Clinical Nuclear Medicine|December 6, 2018
Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016Sied Kebir, Manuel Weber, Lazaros Lazaridis, et al.
Pageof 11